Literature DB >> 22268578

Inflammatory cells in node-negative breast cancer.

Britta Löfdahl1, Cecilia Ahlin, Marit Holmqvist, Lars Holmberg, Wenjing Zhou, Marie-Louise Fjällskog, Rose-Marie Amini.   

Abstract

BACKGROUND: To study the impact of inflammatory cells in a clinically well-defined cohort of women with node-negative breast cancer in a nested case-control study design.
MATERIAL AND METHODS: The cohort was comprised of 190 women who died from breast cancer and 190 women still alive at the date of death for the corresponding breast cancer patients were used as controls. The inclusion criteria included; a tumour size ≤ 50 mm, no lymph node metastases and no initiation of adjuvant chemotherapy. Immunohistochemical stainings for CD3, CD4, CD8, FoxP3, CD20, tryptase and CD68 were performed on TMA blocks, evaluated and correlated to each other and to age, tumour size, histological grade, ER, PgR, Ki67 and cyclin A.
RESULTS: There was no difference regarding the amount or content of inflammatory cells in the cases compared to controls. T- and B-cells were highly correlated to each other but these cell types correlated to a lesser extent to macrophages and not at all to mast cells. A weak tendency of correlations between all the subsets of inflammatory cells and histological grade, Ki67 and cyclin A was observed, although a negative correlation was seen for mast cells.
CONCLUSION: The amount or content of inflammatory cells in invasive breast cancer did not appear to influence death in node-negative breast cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22268578     DOI: 10.3109/0284186X.2011.652737

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

Review 1.  Immune microenvironment in different molecular subtypes of ductal breast carcinoma.

Authors:  Mona Sadeghalvad; Hamid-Reza Mohammadi-Motlagh; Nima Rezaei
Journal:  Breast Cancer Res Treat       Date:  2020-10-03       Impact factor: 4.872

2.  The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.

Authors:  Anna Glajcar; Joanna Szpor; Agnieszka Pacek; Katarzyna Ewa Tyrak; Florence Chan; Joanna Streb; Diana Hodorowicz-Zaniewska; Krzysztof Okoń
Journal:  Virchows Arch       Date:  2017-03-18       Impact factor: 4.064

Review 3.  New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms.

Authors:  Meng Shen; Jian Wang; Xiubao Ren
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

4.  Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer.

Authors:  Noemí Eiró; Iván Pidal; Belen Fernandez-Garcia; Sara Junquera; Maria L Lamelas; José M del Casar; Luis O González; Alfonso López-Muñiz; Francisco J Vizoso
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

5.  The Role of Tumor-Infiltrating B Cells in Tumor Immunity.

Authors:  Fei Fei Guo; Jiu Wei Cui
Journal:  J Oncol       Date:  2019-09-24       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.